Inadvertent presence of pluripotent cells in monolayers derived from differentiated embryoid bodies

MA Ramírez, E Pericuesta, R Fernández-GonzÁLez… - sidalc.net
The therapeutic use of embryonic stem (ES)-derived cells is restricted by a risk of teratoma
formation. To test the hypothesis that some cells with pluripotency characteristics remain …

[引用][C] Inadvertent presence of pluripotent cells in monolayers derived from differentiated embryoid bodies

MA RAMIREZ, E PERICUESTA… - The …, 2007 - University of the Basque Country …
[PDF] academia.edu

[PDF][PDF] Inadvertent presence of pluripotent cells in monolayers derived from differentiated embryoid bodies

MA RAMÍREZ, EVA PERICUESTA… - Int. J. Dev. Biol, 2007 - academia.edu
The therapeutic use of embryonic stem (ES)-derived cells is restricted by a risk of teratoma
formation. To test the hypothesis that some cells with pluripotency characteristics remain …

Inadvertent presence of pluripotent cells in monolayers derived from differentiated embryoid bodies

MÁ Ramírez De Paz, E Pericuesta Camacho… - sidalc.net
The therapeutic use of embryonic stem (ES)-derived cells is restricted by a risk of teratoma
formation. To test the hypothesis that some cells with pluripotency characteristics remain …
[PDF] academia.edu

[PDF][PDF] Inadvertent presence of pluripotent cells in monolayers derived from differentiated embryoid bodies

MA RAMÍREZ, EVA PERICUESTA… - Int. J. Dev. Biol, 2007 - academia.edu
The therapeutic use of embryonic stem (ES)-derived cells is restricted by a risk of teratoma
formation. To test the hypothesis that some cells with pluripotency characteristics remain …